Drug Resistant TB
Decentralization of MDRTB services has continued where by 30 new facilities have been enrolled to make a total of 111 health facilities which provide this service in the country. Up to December 2018 this means 96% (26 out of 27) of all regions have at least one site that can provide MDRTB management.
MDRTB Notification and Enrolment to treatment
In 2018 a total of 449 RR/MDRTB cases were notified country wide among which 409 (91%) were started on MDR TB treatment. As in previous years, Dar es Salaam region contributed the largest proportion of RR/MDR TB cases detected and enrolled on treatment (28%) followed by Mwanza (11%), Geita (6%), Pwani and Mara (5%) each, Morogoro, Mbeya and Lindi each contributed (4%), Arusha and Mtwara (3%) each, other regions had 27% in total except Katavi which did not detect any case. The graph below Figure 15 below shows trend of MDR/RR-TB patients started notified and enrolled.
Figure 1: DR-TB patients detected and started treatment: 2009-2018
Of RR/MDR TB enrolled patients to treatment 266(65.0) were male and 143(35.0%) female, and 122(30.0%) patients were HIV coinfected.
The age of enrolled cases ranged from 10 to 86 years old with a median age of 37 years. About half 54.2% of patients were aged 25 – 44 years. Of all 158 patients enrolled to treatment in 2016, 127 (80.4%) were successfully treated (cured + treatment completed).
Those with unfavourable outcome include; 25 (15.8. %) patients died, 5(3.2%) patients lost to follow up. A review of trends of enrolment and treatment outcomes from 2009 (figure 16) showed the overall linear increase in number of RR/MDR TB patients enrolled to treatment with average success rate of 76% this is higher than the global rate of 56% but its lower than the WHO target of over 90%.
Figure 2: MDR TB Treatment Outcomes 2009 - 2016